JAN88576

• CAT Number: I029723
• CAS Number: 2306388-57-6
• Molecular Formula: C20H13F6NO4
• Molecular Weight: 445.32
• Purity: 98%
• Synonyms: PROTAC ERRα ligand 2; JAN88576; JAN-88576; JAN 88576
• Target: Estrogen Receptor/ERR
• Solubility: To be determined
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (E)-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyanoprop-2-enoic acid
• InChI: InChI=1S/C20H13F6NO4/c1-30-17-7-11(6-13(9-27)18(28)29)2-5-16(17)31-10-12-3-4-14(19(21,22)23)8-15(12)20(24,25)26/h2-8H,10H2,1H3,(H,28,29)/b13-6+
• InChIKey: JRWKJGIKIBTXMV-AWNIVKPZSA-N
• SMILES: COC1=C(C=CC(=C1)/C=C(\C#N)/C(=O)O)OCC2=C(C=C(C=C2)C(F)(F)F)C(F)(F)F

JAN88576（Cat No.:I029723）is an experimental compound investigated for its potential therapeutic applications in the treatment of cancer and other diseases. It belongs to a class of molecules designed to target specific cellular pathways involved in disease progression. In preclinical studies, JAN88576 has demonstrated promising activity in inhibiting tumor growth by affecting key molecular mechanisms related to cell division, survival, and apoptosis. While still under research, the compound holds potential as a novel treatment option in oncology. Further clinical studies are needed to evaluate its safety, efficacy, and optimal usage in human patients.